Description
Prothrombin with INR and Partial Thromboplastin Times - PT/INR: Screening test for abnormalities of coagulation factors that are involved in the extrinsic pathway. Also used to monitor effects of Warfarin therapy and to study patients with hereditary and acquired clotting disorders.
aPTT: The aPTT is a screening test that will detect deficiencies or inhibitors to the intrinsic (Factors VIII, IX, XI and XII) and common (Factors II, V, X and Fibrinogen) pathway coagulation factors.
The prothrombin time (PT) along with its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) are assays which help in evaluating the extrinsic and common pathway of coagulation.
Prothrombin time (PT) evaluates the clotting factors involved in the extrinsic and common pathways of the coagulation cascade together. These include factors I (Fibrinogen), II (Prothrombin), V, VII and X.
International normalized ration (INR) is a calculation from the PT, which regulates for changes in PT reagents .
Activated partial thromboplastin time (aPTT) will evaluate how good the clotting factors involved in the intrinsic and common pathways work together. These include factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen).
This blood test can decide on how quickly the blood clots. It measures how many seconds it takes to clot after reagents are added. It is mostly used to help in detecting a bleeding or clotting disorder. It may be used before surgery or other major procedures sometimes to determine if excessive bleeding or clotting problems may be likely to occur.
